Information about IMXP
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0552.755.587

VAT liability
Yes
Established
16-05-2014
Last balance sheet year
2024
Company size
Medium-sized 26,7 FTE
Full name
ImmunXperts
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from IMXP

2024 2023 2022 2021
Profit/Loss -2,975,828 < -1000% -266,255 -158,07% 458,486 92,63% 238,014
Equity -1,601,929 -214,1% 1,403,965 -20,52% 1,766,549 21,46% 1,454,403
Gross margin 393,338 -84,65% 2,563,153 -6,75% 2,748,794 13,33% 2,425,427
Employees 26.7 24.6 22 18.3

Publications from IMXP

Date Publication
08-01-2026 Resignations, Appointments (FR)
02-02-2024 Registered Office (FR)
04-05-2023 Resignations, Appointments (FR)
14-02-2023 Resignations, Appointments (FR)
31-05-2022 Resignations, Appointments (FR)

Frequently asked questions

What is the VAT number of ImmunXperts?
The VAT number of ImmunXperts is BE 0552.755.587.
Wat is the PEPPOL ID of ImmunXperts?
The PEPPOL ID of ImmunXperts is 0208:0552755587. Log in or start a free trial to see the full overview.
When was ImmunXperts founded?
ImmunXperts was founded on 16-05-2014.
What is the address of ImmunXperts?
The current registered office of ImmunXperts is located at Rue Clément Ader 10, 6041 Charleroi.
When was the last time ImmunXperts filed their annual financial statements?
The most recent financial statements of ImmunXperts were filed on 15-07-2025.
How many employees does ImmunXperts have?
There are 26,7 FTEs working at ImmunXperts according to the staff figures in the most recent financial statements.
What is the annual turnover of ImmunXperts?
At the time of its most recent financial statements, ImmunXperts did not publish any turnover figures. ImmunXperts reported a gross margin of €393,338.22.